Home > Riviste > Italian Journal of Emergency Medicine > Fascicoli precedenti > Italian Journal of Emergency Medicine 2021 April;10(1) > Italian Journal of Emergency Medicine 2021 April;10(1):30-3

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

COMMENTARY  COVID-19 SECTION Open accessopen access

Italian Journal of Emergency Medicine 2021 April;10(1):30-3

DOI: 10.23736/S2532-1285.21.00084-7

Copyright © 2021 THE AUTHORS

This is an open access article distributed under the terms of the CC BY-NC-ND 4.0 license which allows users to copy and distribute the manuscript, as long as this is not done for commercial purposes and further does not permit distribution of the manuscript if it is changed or edited in any way, and as long as the user gives appropriate credits to the original author(s) and the source (with a link to the formal publication through the relevant DOI) and provides a link to the license.

lingua: Inglese

Clinical indications for anti-COVID-19 antibodies use

Luigi PETRAMALA 1, 2 , Giuliana GUERRIZIO 3, Marianna CALABRETTO 3, Massimo GENTILE 4, Sapienza MEU Group 

1 Department of Emergency, Critical Areas and Trauma, Umberto I Polyclinic Hospital, Sapienza University, Rome, Italy; 2 Department of Translational and Precision Medicine, Sapienza University, Rome, Italy; 3 Umberto I Polyclinic Hospital, Sapienza University, Rome, Italy; 4 Department of Molecular Medicine, Sapienza University, Rome, Italy



inizio pagina